Vitafol Fe+ By Exeltis USA Overview & Drug Interactions

Check For Interactions With Vitafol Fe+

Supplement: Vitafol Fe+ by Exeltis USA

Vitafol Fe+ Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Vitafol Fe+ by Exeltis USA

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Softgel Capsule(s)
Maximum serving Sizes:
1 Softgel Capsule(s)
Servings per container 30
UPC/BARCODE 306427473305

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin A
330 mcg RAE
Vitamin A 14%
Vitamin C
60 mg
Vitamin C 100%
Vitamin D
25 mcg
Vitamin D 250%
Vitamin E
9 mg
Vitamin E (unspecified) 67%
Thiamine
1.6 mg
Thiamin 94%
Riboflavin
1.8 mg
Riboflavin 90%
Niacin
15 mg NE
Vitamin B3 (Niacinamide) 75%
Vitamin B6
2.5 mg
Vitamin B6 100%
Folate
1700 mcg DFE
Folate 125%
Folic Acid
680 mcg DFE
Folate
L-Methylfolate Calcium
1020 mcg DFE
Vitamin B9 (5-Methyltetrahydrofolate)
Vitamin B12
25 mcg
Vitamin B12 313%
Iron
90 mg
Iron 500%
Iodine
150 mcg
Iodine 100%
Magnesium
20 mg
Magnesium 4%
Zinc
25 mg
Zinc 167%
Copper
2 mg
Copper 100%
Algal Oil Blend
415 mg
Algal Oil --
Docosahexaenoic Acid
200 mg
DHA (Docosahexaenoic Acid)

Other Ingredients:
Gelatin
Soybean Oil
Sorbitol
Glycerin
yellow Beeswax
Water, Purified
Lecithin
Titanium Dioxide
FD&C Red #40
FD&C Blue #1
White Edible Ink


Label Statments:


Formula
- Complete prenatal supplement with 90 mg iron
- Usage: Vitafol Fe+ prenatal supplement provides vitamin, mineral, and omega-3 fatty acid supplementation throughout pregnancy, including individuals with known allergies to fish.
- Vital nutrition for women who need more iron.
General Statements
- 0642-7473-30 Unit dose pack
- How Supplied: Vitafol Fe+ is available as a purple, oval shaped softgel capsule imprinted "EX0096". Available in Box of Unit-Dose pack of 30 count (5 child resistant blister cards containing 6 softgel capsules), 0642-7473-30 and as professional samples 0642-7473-01.
- See package insert for full prescribing information
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- U.S. Patent Pending
- Copyright 2021 Exeltis USA, Inc.
- Vitafol is a trademark of Exeltis USA, Inc. U.S. Patent Pending Metafolin is a trademark of Merck KGaA, Darmstadt, Germany. U.S. Patent No. 6,441,168B1; 5,997,915; 6,254,904; 6,808,725; 7,172,778 and 7,674,490
Precautions
- Contains: Soy. May contain: Corn oil, medium chain triglycerides.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of of accidental overdose, call a doctor or a poison control center immediately.
Formulation
- Vitafol Fe+ does not contain fish oil, fish proteins or fish byproducts.
Suggested/Recommended/Usage/Directions
- Directions for use: During pregnancy, take one softgel capsule daily, or as directed by a physician.
Storage
- Store at room temperature, approximately 15 degrees - 30 degrees C (59 degrees - 86 degrees F), avoid excessive heat above 30 degrees C (86 degrees F), light and moisture.

Brand Information

See all products by this brand

Distributed by
Name Exeltis USA, Inc.
City Florham Park
State NJ
ZipCode 07932
Phone Number 1-877-324-9349
Web Address www.exeltisUSA.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.